Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Oct;37(10):3229-32.
doi: 10.1128/JCM.37.10.3229-3232.1999.

Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test

Affiliations

Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test

S Pottumarthy et al. J Clin Microbiol. 1999 Oct.

Abstract

We evaluated an in vitro test of cell-mediated immunity, the tuberculin gamma interferon assay, QuantiFERON-TB (QIFN), in 455 individuals from three groups: group I, 237 immigrants from high-risk countries; group II, 127 health care workers undergoing Mantoux testing; group III, 91 patients being investigated for possible active tuberculosis (79 patients) or Mycobacterium avium-Mycobacterium intracellulare complex infection (12 patients). The QIFN results were compared either to those of the Mantoux test or to microbiological and clinical diagnosis, as appropriate. In each group the correlation between the diameter of induration for the skin test and the magnitude of QIFN response was significant and of moderate strength (Spearman's rank correlation coefficient; rho = 0.59 to 0.61; P < 0.001). For group I, the agreement between QIFN and Mantoux results was 89% for Mantoux-negative and 64% for Mantoux-positive individuals. For group II, when >/=10-mm-diameter induration was taken as positive, the agreement was 81% for Mantoux-negative and 67% for Mantoux-positive individuals. For group III, agreement was 81% for Mantoux-negative and 86% for Mantoux-positive patients. For patients being evaluated for active tuberculosis, the performance of the Mantoux test was not statistically different from that of the QIFN assay. In patients with active tuberculosis, the assay had a sensitivity of 77%, not significantly higher for extrapulmonary than pulmonary cases (83% versus 74%). QIFN sensitivity was not significantly different for smear-negative or smear-positive cases (80% versus 71%). The QIFN assay is a potential replacement for the Mantoux test. The acceptability of these performance values and those of similar evaluations will determine the place this test will have in detecting evidence of mycobacterial infection.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Correlation between percent QIFN response and Mantoux induration diameter in patients being evaluated for active tuberculosis. The percent QIFN response versus the Mantoux induration diameter is stratified as either 0, 1 to 9, 10 to 19, or ≥20 mm of induration. The solid bars represent medians, the boxes indicate the interquantile ranges, and the lines show the most extreme observations within 1.5 times the interquantile range. There was one extreme outlier with a value of 1,043% QIFN response in the 0-mm Mantoux group. The correlation between the QIFN result and Mantoux induration diameter was significant and of moderate strength (Spearman’s rank correlation coefficient = 0.61; P < 0.001).

References

    1. Bothamley G H. Serological diagnosis of tuberculosis. Eur Respir J. 1995;8(Suppl. 20):676–688. - PubMed
    1. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare facilities. Morbid Mortal Weekly Rep. 1994;43(RR-13):59–64. - PubMed
    1. Chaparas S D, Vandiviere H M, Melvin I, Koch G, Becker C. Tuberculin test. Variability with the Mantoux procedure. Am Rev Respir Dis. 1985;132:175–177. - PubMed
    1. Converse P J, Jones S L, Astemborski J, Vlahov D, Graham N M H. Comparison of a tuberculin interferon-γ assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis. 1997;176:144–150. - PubMed
    1. Desem N, Jones S L. Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol. 1998;5:531–536. - PMC - PubMed